Hosted on MSN6mon
AstraZeneca Defends China Compliance In Wake of Staff Detentions(Bloomberg) -- AstraZeneca Plc has strong compliance policies in China and is working closely with authorities following the detention of several employees in the country, Chief Executive Officer ...
BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results